Oct 18 (Reuters) - Immuron Ltd IMC.AX :
* IMMURON ANNOUNCES TRAVELAN® CLINICAL STUDY COHORT 2
COMMENCES
* IMMURON ANNOUNCES TRAVELAN® CLINICAL STUDY COHORT 2
COMMENCES
* IMMURON LTD - SECOND COHORT OF 34 HEALTHY VOLUNTEERS
ENROLLED IN
TRAVELAN(®) CLINICAL TRIAL
* IMMURON LTD - HEADLINE RESULTS FROM CLINICAL TRIAL ARE
ANTICIPATED TO BE REPORTED IN JUNE 2024
* IMMURON LTD - INPATIENT PHASE FOR SECOND COHORT WILL BE
COMPLETED BY END OF OCTOBER 2023
Source text for Eikon: ID:nGNX6NrcjG
Further company coverage: IMC.AX
((reuters.briefs@thomsonreuters.com;))